List of Tables
Table 1. Global Cancer Immunotherapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immune Checkpoint Inhibitors
Table 3. Key Players of Immune System Modulators
Table 4. Key Players of Cancer Vaccines
Table 5. Global Cancer Immunotherapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cancer Immunotherapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cancer Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cancer Immunotherapy Market Share by Region (2019-2024)
Table 9. Global Cancer Immunotherapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cancer Immunotherapy Market Share by Region (2025-2030)
Table 11. Cancer Immunotherapy Market Trends
Table 12. Cancer Immunotherapy Market Drivers
Table 13. Cancer Immunotherapy Market Challenges
Table 14. Cancer Immunotherapy Market Restraints
Table 15. Global Cancer Immunotherapy Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cancer Immunotherapy Market Share by Players (2019-2024)
Table 17. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2023)
Table 18. Ranking of Global Top Cancer Immunotherapy Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cancer Immunotherapy Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cancer Immunotherapy Product Solution and Service
Table 22. Date of Enter into Cancer Immunotherapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cancer Immunotherapy Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cancer Immunotherapy Revenue Market Share by Type (2019-2024)
Table 26. Global Cancer Immunotherapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cancer Immunotherapy Revenue Market Share by Type (2025-2030)
Table 28. Global Cancer Immunotherapy Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cancer Immunotherapy Revenue Market Share by Application (2019-2024)
Table 30. Global Cancer Immunotherapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cancer Immunotherapy Revenue Market Share by Application (2025-2030)
Table 32. North America Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cancer Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cancer Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cancer Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cancer Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cancer Immunotherapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cancer Immunotherapy Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cancer Immunotherapy Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cancer Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cancer Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cancer Immunotherapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cancer Immunotherapy Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cancer Immunotherapy Market Size by Country (2025-2030) & (US$ Million)
Table 47. Amgen Company Detail
Table 48. Amgen Business Overview
Table 49. Amgen Cancer Immunotherapy Product
Table 50. Amgen Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 51. Amgen Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca Cancer Immunotherapy Product
Table 55. AstraZeneca Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Roche Company Detail
Table 58. Roche Business Overview
Table 59. Roche Cancer Immunotherapy Product
Table 60. Roche Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 61. Roche Recent Development
Table 62. Bayer Company Detail
Table 63. Bayer Business Overview
Table 64. Bayer Cancer Immunotherapy Product
Table 65. Bayer Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Bristol-Myers Squibb Company Detail
Table 68. Bristol-Myers Squibb Business Overview
Table 69. Bristol-Myers Squibb Cancer Immunotherapy Product
Table 70. Bristol-Myers Squibb Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 71. Bristol-Myers Squibb Recent Development
Table 72. Eli Lilly Company Detail
Table 73. Eli Lilly Business Overview
Table 74. Eli Lilly Cancer Immunotherapy Product
Table 75. Eli Lilly Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 76. Eli Lilly Recent Development
Table 77. Merck Company Detail
Table 78. Merck Business Overview
Table 79. Merck Cancer Immunotherapy Product
Table 80. Merck Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Novartis Company Detail
Table 83. Novartis Business Overview
Table 84. Novartis Cancer Immunotherapy Product
Table 85. Novartis Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 86. Novartis Recent Development
Table 87. Pfizer Company Detail
Table 88. Pfizer Business Overview
Table 89. Pfizer Cancer Immunotherapy Product
Table 90. Pfizer Revenue in Cancer Immunotherapy Business (2019-2024) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Immunotherapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cancer Immunotherapy Market Share by Type: 2023 VS 2030
Figure 3. Immune Checkpoint Inhibitors Features
Figure 4. Immune System Modulators Features
Figure 5. Cancer Vaccines Features
Figure 6. Global Cancer Immunotherapy Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cancer Immunotherapy Market Share by Application: 2023 VS 2030
Figure 8. Lung Cancer Case Studies
Figure 9. Breast Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Melanoma Case Studies
Figure 12. Prostate Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. Cancer Immunotherapy Report Years Considered
Figure 15. Global Cancer Immunotherapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 16. Global Cancer Immunotherapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 17. Global Cancer Immunotherapy Market Share by Region: 2023 VS 2030
Figure 18. Global Cancer Immunotherapy Market Share by Players in 2023
Figure 19. Global Top Cancer Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Immunotherapy as of 2023)
Figure 20. The Top 10 and 5 Players Market Share by Cancer Immunotherapy Revenue in 2023
Figure 21. North America Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. North America Cancer Immunotherapy Market Share by Country (2019-2030)
Figure 23. United States Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Canada Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Cancer Immunotherapy Market Share by Country (2019-2030)
Figure 27. Germany Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. France Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. U.K. Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Italy Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Russia Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Nordic Countries Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Cancer Immunotherapy Market Share by Region (2019-2030)
Figure 35. China Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Japan Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. South Korea Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Southeast Asia Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. India Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Australia Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Cancer Immunotherapy Market Share by Country (2019-2030)
Figure 43. Mexico Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Brazil Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Cancer Immunotherapy Market Share by Country (2019-2030)
Figure 47. Turkey Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Cancer Immunotherapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Amgen Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 50. AstraZeneca Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 51. Roche Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 52. Bayer Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 54. Eli Lilly Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 56. Novartis Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 57. Pfizer Revenue Growth Rate in Cancer Immunotherapy Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed